Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.
Lee KH, Kim MK, Kim YH, Ryoo BY, Lim HY, Song HS, Kim HK, Lee MA, Im SA, Chang HM, Cho JY, Zang DY, Kim BS, Kim JS.
Lee KH, et al. Among authors: kim yh, kim bs, kim hk, kim js, kim mk.
Cancer Chemother Pharmacol. 2009 Jul;64(2):317-25. doi: 10.1007/s00280-008-0873-9. Epub 2008 Nov 26.
Cancer Chemother Pharmacol. 2009.
PMID: 19034448
Clinical Trial.